In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles

ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)


Volume 17, 15 Issues, 2016


Download PDF Flyer




Current Pharmaceutical Biotechnology

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 152nd of 255 in Pharmacology & Pharmacy
  • 213th of 290 in Biochemistry & Molecular Biology

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Zeno Foldes-Papp
Christian Clinical Center Siegen-Kreuztal
Siegen-Kreuztal
Germany


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.802
5 - Year: 2.327

In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles



Current Pharmaceutical Biotechnology, 14(12): 1062-1071.

Author(s): Huile Gao, Chen Chen, Zhangjie Xi, Jun Chen, Qizhi Zhang, Shilei Cao and Xinguo Jiang.

Affiliation: School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education, 826 Zhangheng Road, Shanghai, 201203, China.

Abstract

To improve the solubility, bioavailability and anti-tumor effect of lapatinib, lapatinib-incorporated lipid nanoparticles (LTNPs) were prepared and characterized. The particle size of LTNPs was 88.6 nm with a zeta potential of 20 mV. Laptinib was loaded into LTNPs with a non-crystal structure as determined by FT-IR. In vitro, LTNPs could be effectively uptaken into C6 glioma cells at a concentration-dependent manner. In vivo, LTNPs showed a relative higher AUC, which was 5.27- and 3.21-fold as that of Tykerb and lapatinib suspension (LTS) group. LTNPs also showed highest glioma concentration, which may benefit from the enhanced permeability and retention effect and active targeting ability. In toxicity studies, LTNPs displayed a half lethal dose over 250 mg/kg. Repeated administering 30 mg/kg of LTNPs could led to toxicity to hematology which might owe to the bovine serum albumin, a foreign protein to mice. However, there was no organic change observed through HE staining. In conclusion, LTNPs could target to glioma with high concentration and low side effect.

Keywords:

Lapatinib, pharmacokinetic, tissue distribution, toxicity.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 14
Issue Number: 12
First Page: 1062
Last Page: 1071
Page Count: 10
DOI: 10.2174/1389201015666140113110746
Price: $58
Advertisement
Pharmaceutical Microbiology 2017

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science